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Cutaneous squamous cell carcinoma (cSCC)
Epidemiology
A B S T R A C T
Actinic keratosis (AK) arises on photo-damaged skin and is considered to be the precursor lesion of cutaneous
squamous cell carcinoma (cSCC). Many findings support the involvement of β human papillomaviruses (HPVs) in
cSCC, while very little is known on γ HPV types. The objective of this study was to characterize the spectrum of
PV types in healthy skin (HS) and AK samples of the same immunocompetent individuals using next generation
sequencing (NGS). Viral DNA of 244 AK and 242 HS specimens were amplified by PCR using two different sets of
primers (FAP59/64 and FAPM1). Purified amplicons were pooled and sequenced using NGS. The study resulted
in the identification of a large number of known β and γ PV types. In addition, 27 putative novel β and 16 γ and 4
unclassified PVs were isolated. HPV types of species γ-1 (e.g. HPV4) appeared to be strongly enriched in AK
versus HS. The NGS analysis revealed that a large spectrum of known and novel PVs is present in HS and AK. The
evidence that species γ-1 HPV types appears to be enriched in AK in comparison to HS warrants further studies to
evaluate their role in development of skin (pre)cancerous lesions.
1. Introduction
Cutaneous squamous cell carcinoma (cSCC) arises from progression
of the precursor lesion, actinic keratosis (AK), which develops on photo-
damaged skin [1]. Ultraviolet (UV) radiation exposure is the main risk
factor in the development of AK and cSCC [2,3]. Skin lesion develop-
ment is also positively associated with fair skin, advanced age and
immunosuppression [4]. The concept that impairment of the immune
system favors cSCC development supports the involvement of an in-
fectious agent, such as the epitheliotropic human papillomaviruses
(HPVs). HPVs are circular double-stranded DNA viruses infecting mu-
cosal and cutaneous epithelia. To date, more than 200 HPV genotypes
have been fully characterized and classified into five genera (α, β, γ, mu
and nu papillomaviruses) according to the nucleotide sequences of the
ORF encoding for the major capsid protein L1 [5] (https://pave.niaid.
nih.gov/). A subgroup of α-genus HPV types, referred to as mucosal
high-risk (HR) HPV types, has been clearly associated with human
carcinogenesis [6,7]. Twelve HR HPV types, namely 16, 18, 31, 33, 35,
39, 45, 51, 52, 56, 58, 59 have been classified as Group 1, carcinogens
to humans, by the International Agency for Research on Cancer (IARC)
[8]. In addition to the mucosal HR HPV types, epidemiological and
biological studies support the role of β-genus HPV types in the devel-
opment of cSCC, together with UV radiation [9]. The first β HPV types,
HPV5 and 8, were identified in skin lesions of epidermodysplasia verru-
ciformis (EV) patients, who are highly susceptible to β HPV infection
and UV-induced cSCC [10,11]. Accordingly, IARC has classified β HPV
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5 and HPV 8 as “possibly carcinogenic” agents (Group 2B) in EV pa-
tients [8]. Since their isolation, additional 52 β HPV types have been
characterized so far, which are subdivided into 5 species, β1-5 (http://
www.nordicehealth.se/hpvcenter/reference_clones/) [12] and are
abundantly present on the skin of healthy individuals [13–16]. In ad-
dition to EV patients, β HPV types appear to be involved in cSCC de-
velopment also in immunocompromised individuals, such as organ
transplant recipients (OTR), as well as in elderly general population
[17–20]. In contrast to α HR HPV types, the presence of β HPVs does
not appear to be required for the maintenance of the malignant phe-
notype [21]. Studies in in vivo experimental models provide evidence
for a “hit-and-run” mechanism of β HPVs involvement in UV-induced
skin carcinogenesis [1,21–23]. Accordingly β HPV prevalence and viral
load decrease during carcinogenesis process in humans, being sig-
nificantly higher in AK than in cSCC [24,25]. Other cutaneous HPV
types that are frequently detected in skin are the ones that belong to γ
genus. They represent the largest clade within the Papillomaviridae fa-
mily. Almost 100 γ HPV types subdivided into 27 species have been
fully characterized so far. No clear association of γ HPVs with malig-
nant lesions has been demonstrated, although biological studies showed
that E6 and E7 proteins from some γ HPVs display in vitro transforming
activities [26].
To gain new insights on the presence of a broad spectrum of β and γ
HPV types in healthy skin (HS) and actinic keratosis (AK) of the same
individual, we used different PCR protocols [27–29] combined with
Next Generation Sequencing (NGS). We used the well-validated broad-
spectrum FAP primers and an updated version FAPM1 primers. The
latter set of primers was designed taking into consideration DNA se-
quences of recently characterized beta HPV types [27–29]. The results
revealed the presence of a large spectrum of β and γ HPV types. In-
terestingly, species γ-1 HPV types appear to be more represented in AK
than in HS.
2. Materials and methods
2.1. Patient selection, sample collection and DNA extraction
Skin scraping samples (HS and AK) from a previous study aimed to
determine the prevalence of cutaneous HPVs in AK lesions by using a
sensitive Luminex based-beads multiplex assay were used in the present
analysis [30]. Skin samples were collected from 244 immunocompetent
patients (142 men and 102 women in age range 48–94 years) with a
diagnosis of AK attending the dermatology outpatient clinic of the
National Institute for Health, Migration and Poverty (NIHMP) in Rome
(Italy). A total of 488 individual samples were collected by scraping the
lesions and, separately, the healthy skin of the glabellar region with a
sterile spatula. The majority of the AK lesions were in the head region
(n = 221) while others were located in the limbs (n = 5) and other
anatomical sites (n = 18). In the present analysis, two HS samples were
excluded due to the shortage of the residual sample. Samples were
stored at −80 °C until treatment with proteinase K for 4 h at 50 °C in
10 mM Tris-HCl pH 8.0, 50 mM NaCl, 5 mM EDTA, 1 mM DTT, 0.5%
SDS (0.4 ml/sample). Nucleic acids, extracted by magnetic silica using
the automated system NucliSENS EasyMag (Biomérieux, France) ac-
cording to the manufacturer's directions, were analyzed at IARC (Lyon,
France) by NGS. Written informed consent was obtained from all en-
rolled patients. The study was approved by the Ethical Commettes of
both NIHMP (2014) and San Gallicano Dermatologic Institute (CE943/
17).
2.2. PCR amplification and amplicon purification
Extracted DNA was amplified using two different sets of primers; the
consensus primer pair FAP (FAP59\FAP64) targeting the 5′end of the
L1 ORF as previously reported [27], and a new set of degenerated FAP
primers (FAPM1 primer mix) as previously described by Brancaccio
et al. [29]. Both FAP and FAPM1 primers target a region of the L1 ORF
yielding an amplicon of about 480 bp. PCR amplicons were visualized
by electrophoresis on a 2% agarose gel and purified using QIAquick gel
extraction purification kit according to the manufacturer's instructions
(QIAGEN, Hilden, Germany).
2.2.1. Library preparation and NGS
Purified PCR amplicons were divided into twelve different pools as
described in Table 1. Each pool was obtained using 2 μl of each purified
PCR product. Before library preparation, one additional purification
step was performed in each pool to remove any residual contaminants
using the Agencourt AMPure XP PCR purification kit with a beads ratio
of 1.8 X (Beckman Coulter) according to the manufacturer's instruc-
tions.
Twelve libraries were prepared using the Nextera ™ DNA Flex
Library preparation kit (Illumina, San Diego, CA, US). Illumina MiSeq
dual-indexed adapters (Illumina, San Diego, CA, US) were added to
each of the PCR pools. The library sizes were checked using the
Bioanalyzer 2100 Expert (Agilent) using high sensitivity DNA assay.
NGS analysis was performed on 4 nM of DNA pooled library using an
Illumina MiSeq instrument (2 × 150 paired-end reads with the Illumina
MiSeq kit v3). In order to enrich the diversity of the libraries, 10% of
PhiX (Illumina, San Diego, CA, US) was added to the NGS reaction.
2.2.2. Bioinformatic analysis of NGS sequences
The bioinformatic workflow includes common data preprocessing
steps for quality control and filtering. Then, data complexity is reduced
before the identification of the PV-related sequences. Groups of se-
quences are defined based on similarity between identified sequences
and available PVs sequences in the NCBI database. De-novo assembly is
then performed to reconstruct the full amplified region covered by
several primers systems. Finally, the reconstructed sequences are tax-
onomically classified based on two independent methodologies: align-
ment-based, and homology-based, respectively, before generation of
diverse output reports. Details of the bioinformatic pipeline named
“PVAmpliconFinder” and parameters used can be found in (https://
github.com/IARCbioinfo/PVAmpliconFinder).
All the results in this study are based on the identification of the
sequences following the homology-based classification using the evo-
lutionary placement algorithm (EPA) in RAxML (Randomized
Axelerated Maximum Likelihood) [31,32] (henceforth referred to as
RAxML-EPA). Only the longest sequence was considered for RAxML-
EPA classification when several singlets or contigs were available.
Table 1
Description of the NGS pools. All the PCR products (n = 685) were grouped
in 12 NGS pools according to the type of skin sample and PCR protocol applied
as indicated in the table. For pools 1–3, 2–4, 5–7, 6 both HS and AK specimens
of the same individuals gave a PCR product with indicated primers. In contrast
the remaining pools include PCR products of unpaired AK (9−10) or HS
(11–12), since the matched skin samples were negative with indicated PCR
protocols.
NGS pool PCR protocol Specimen (AK or HS)∗ Total number
1 FAP59/64 AK 71
3 FAP59/64 HS 71
2 FAP59/64 AK 70
4 FAP59/64 HS 70
5 FAPM1 AK 53
7 FAPM1 HS 53
6 FAPM1 AK 53
8 FAPM1 HS 53
9 FAP59/64 AK 34
10 FAPM1 AK 16
11 FAP59/64 HS 41
12 FAPM1 HS 100
∗ AK, actinic keratosis; HS, healthy skin.
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3. Results
3.1. HPV DNA PCR amplification and NGS analyses
Amplicons of the expected size were detected in 75.2% (182/242)
and in 85.1% (206/242) of HS samples, using FAP59/FAP64 and
FAPM1 protocols, respectively. A PCR product of the expected size was
detected in 71.2% (175/244) and in 50% (122/244) of the AK samples
by using the primer sets FAP59/FAP64 and the novel FAPM1, respec-
tively.
PCR amplicons generated by the use of the two different sets of
primers on HS and AK DNA samples were pooled as shown in method
section and sequenced using the NGS platform MiSeq Illumina. The
NGS analysis generated a total of 1,209,249 reads. A total of 1,208,356
of the reads was considered for further analysis after quality trimming,
and chimeric PCR sequence removal. All of them, were identified as
related to PVs sequences (> 99% of reads). Each read was matched
against the National Center for Biotechnology Information (NCBI) se-
quences database by means of BLAST algorithm and assigned to its
closest PV types.
The different PV sequences were analyzed following the official
taxonomic HPV classification based on the similarity in L1 ORF [5].
Data analysis obtained using RAxML-EPA, a method that offers an
accurate classification of short PV fragments, reported that the
1,208,356 reads analyzed comprised 1,204,447 (99.7%) reads from
known PVs (≥90% of identity with L1 ORF of any known PV), while
the remaining reads (n = 3909) corresponded to novel putative PVs
(< 90% of identity with L1 ORF of any known PV). The majority of the
reads (81.1%, 976,693 reads) corresponded to β PVs, followed by γ
(17.3%, 208,932 reads) and α types (0.01%, 121 reads) (Table 2).
According to RaxML-EPA analysis of known PV sequences, the major
number of reads were related to human PVs (n = 1,181,306), while the
remaining were closely related to non-human PVs (total non-human
reads: 23,141) i.e.Macaca fascicularis PV type 2 (MfPV2) belonging to β-
6 genus (3769 reads), Macaca mulatta papillomavirus type 5 (MmPV5)
(671 reads) that is classified into the γ genus, and Erethizon dorsatum
papillomavirus 2 (EdPV2) (18,701 reads), a new PV still unclassified
(Table S1). In summary, 1,204,447 reads are representative of 1786 PVs
sequences. As a specific PV sequence can be represented more than one
time among the different pools, or different PV sequences can be as-
signed to the same PV type, thus 1786 PV sequences corresponded to
195 distinct PV types (Table 2 and Table S1). Of the 195 PV types, 93
resulted to be officially recognized, namely 2 sequences from α-2 spe-
cies, 49 sequences from β 1–6 and 42 sequences spreading into 18 γ
species (Fig. 1). The remaining sequences corresponded to 12 un-
classified-β and 89 unclassified-γ PVs. Only one sequence remained
unclassified and was assigned by RAxML-EPA analysis to a divergent
and unclassified EdPV2 sequence (Tables 2 and S1).
3.1.1. Known PV sequences in HS and AK
We next compared the distribution of the different PVs sequences in
AK and HS. The distribution of all known HPV types detected in HS and
AK is shown in Table S1 and the relative abundance is in Fig. 1. Re-
garding α HPV types, the small number of reads (n = 121) generated
exclusively by the FAPM1 protocol corresponded to sequences of the
two closely related cutaneous HPVs 3 and 28. However, most of the
reads were from HPV28, which was equally distributed in HS and AK
(Table S1). Reads of β HPV sequences were approximately equally re-
presented in HS and AK (485,918 and 490,775 respectively), with the
exception of β-4 species, represented by HPV type 92 only. For this the
number of reads was more abundant in AK than HS (1440 vs 198 reads)
(Fig. 1a, Table S1).
Regarding the γ HPV types, reads for the different species were
differently detected in HS (85,568 reads) and AK (123,364 reads)
samples. The relative abundance of γ-types was in some cases higher in
AK than the relative abundance in HS (i.e. γ-1, γ-3, γ-7, γ-8, γ-9, γ-11, γ-
15,γ-17) and vice versa in other cases (i.e. γ-12, γ-13, γ-21, γ-24)
(Fig. 1b). Moreover, for the majority of the species only a small number
of reads were detected in HS and AK (i.e γ −4, γ-20 and γ −25). In-
terestingly, for γ-1 species 600 fold difference in number of reads was
observed in AK versus HS (13,248 and 22 reads, respectively) (Fig. 1b
and Table S1). The majority of these γ-1 reads corresponded to HPV4
(13,207 reads) (Table S1).
3.1.2. Putative novel PVs
Finally, 3909 (0.3%) reads generated a total of 47 putative novel PV
types, since the fragment sequence showed less than 90% similarity to
L1 ORF of any known PVs. As per the RaxML-EPA classification, the
majority of reads were closely related to human PVs (3827 reads). Of
the 3827 reads, a substantial number of reads were closely related to β-
HPVs (3457 reads), and γ-HPVs (370 reads). Whereas, for the non-
human PVs, out of 82 reads, 74 reads were from the unclassified PVs
category (Table S2).
Among the unknown PV sequences, 26 (55.3%) putative novel se-
quences were found in HS and 21 (44.7%) in AK specimens, respec-
tively (Tables 2 and S2). The FAPM1 primers detected a slightly higher
number of putative novel HPV sequences than FAP59/64, i.e. 27 and
20, respectively (Table 2).
Using RAxML-EPA classification, 15 putative novel β PVs and 11
putative novel γ PVs were isolated from HS samples, whereas 12 novel
β PVs and 5 γ PVs were isolated from AK samples. The remaining 4
putative novel PVs, isolated from AK samples, remained unclassified
(Table 2).
The FAPM1 protocol allowed the isolation of a total of 12 novel γ
Table 2
Known and putative novel PVs sequences in healthy skin (HS) and actinic keratosis (AK) samples. The number of sequences and corresponding reads are
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PVs in AK and HS samples, while the FAP protocol allowed the isolation
of 4 γ PVs only in HS samples (Tables 2 and S2).
Putative new PV types in AK samples were related to HPV5, 21
(belonging to species β-1), HPV15, 22, 23, 120 (species β-2) and
HPV130 (species γ-10) (Table S2). In HS samples, the new PV sequences
were related to species β-1 (HPV5, 21, 24), β-2 (HPV22, 23, 38), γ-10
(HPV133) and γ-27 (HPV201).
4. Discussion
Cutaneous HPV types spread over all five HPV genera and are
abundantly present in normal skin. Since several lines of evidence
support the role of β HPV types in favoring the UV-induced skin car-
cinogenesis, epidemiological studies focused mostly only on β-HPV
detection in pre-malignant and malignant skin lesions. In contrast to β
HPV types, the biology and epidemiology of γ HPV types have been
poorly investigated so far. In a recent study, we have determined the
prevalence of 46 β and 52 γ HPV types in HS and AK of the same in-
dividuals who have been included in this study [30]. Dona et al. re-
ported that the prevalence of most of the β and γ HPV types decreased
from HS to AK, suggesting that cutaneous HPVs may play a role at early
phase of AK lesion development and can be lost once the lesion is fully
established [30]. To have a more accurate scenario on the HPV types
present in HS and AK, we have re-analyzed the same cohort performing
Fig. 1. Detected PV species in HS and AK samples. Relative abundance of species (%) beta (1a) and gamma (1b) according to RaxML-EPA classification in both
healthy skin (HS) and actinic keratosis (AK) samples are shown.
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a broad spectrum analysis of cutaneous HPV types by NGS. Our data
confirmed previous findings that β1 and β2 are the most represented
species in both HS and AK, followed by β3, β4 and β5 [30,33]. It is not
yet clear why the β4 and β5 HPV types are poorly present in the skin.
One possible hypothesis is that these HPVs have a low efficiency in
persisting in the host skin. Alternatively, β3-5 HPV types may pre-
ferentially infect other anatomical sites than the skin. In support of this
hypothesis, it has been shown that β3 are more prevalent in mucosal
epithelia than in the skin [33,34]. In agreement with the epidemiolo-
gical data, functional studies revealed that β3 HPV types 49 shares
some biological properties with the mucosal HR HPV16 in vitro and in
vivo experimental models [35–37].
The γ genus is the largest clade within the Papillomaviridae family
and the improvement of sequencing methods has led to the identifica-
tion of many novel γ types over the last years [38–40]. The γ PVs can be
found in common warts, in skin tumors and AK samples, as well as in
normal skin [30,41–43]. Our NGS-based analysis revealed that almost
all γ species were represented in HS and AK, except for γ-2, γ-5, γ-6, γ-
14, γ-18 and γ-23. In addition to this, a relevant number of γ species
that are not yet classified by the HPV reference center was also found.
However, one limitation of our study is that it does not provide in-
formation on the distribution of specific HPV types in HS and AK in
single individuals, since PCR amplicon pools were generated for the
next-generation sequencing.
Interestingly, although most of the β and γ HPV types were equally
represented in HS and AK samples, γ-1 HPV4 was strongly enriched in
AK samples versus HS. Similar results were observed in our recent study
where HPV detection was performed by a highly specific genotyping
assay [30]. In this study, using the same samples, the number of reads
that correspond to HPV4 was indeed higher in AK (13,207 reads) in
comparison to HS (20 reads). These findings suggest a possible link
between HPV4 infection and AK development. Alternatively, this spe-
cific γ HPV type might have some biological differences with respect to
the other γ HPV types, for instance it could benefit from the tissue al-
terations occurring in AK for completion of its life cycle. Additional
work is required to further evaluate these two hypothesis. So far, it has
been reported that HPV4 is associated with the development of mosaic
warts [44,45]. Regarding HPV4 biological properties, it has been shown
that its E7 is able to degrade pRb [46], as the mucosal HR HPV E7s.
Mutations in the EVER1 or EVER2 have been associated with high
susceptibility to cutaneous HPV infection and the development of the
EV disease [47]. It has been recently shown that EVER1/EVER2 form a
complex with the encoding the pleiotropic factor calcium- and integrin-
binding protein 1 (CIB1) [48]. Interestingly, HPV4 E8 interacts with
CIB1, suggesting that this virus may interfere with EVER1/EVER2/
CIB1-dependent restriction of viral infection.
In the present study we identify 195 known HPV types and in ad-
dition to this, using different PCR protocols combining with NGS, we
identified 47 putative novel PVs. The analysis of these putative novel
PVs revealed that they are related to 27 β, 16 γ and 4 unclassified PVs.
Of which, 1 β PV, 1 γ and 4 unclassified PVs were non-human PVs. The
classification of these PVs as animal types relies on short DNA se-
quences. The complete characterization of the entire genome could
result in a different classification as novel HPVs. However, the possi-
bility that these PVs represent a contamination from domestic animals
or have crossed the species should be also taken into consideration.
Interestingly, our study led to the identification of 15 putative novel
β-2 HPV types. β-2 species includes HPV38, which displays in vitro and
in vivo transforming properties. Also HPV38 has been found sig-
nificantly associated with the risk of cSCC in a recent meta-analysis
[49].
5. Conclusions
In summary, using a robust strategy based on the use of degenerated
primers and NGS technology this study expanded our knowledge and
efficiently depicted the PV population in AK and HS sample. Moreover,
it allowed the detection of putative novel PVs, although the identifi-
cation of novel PV types or species can only be definitively confirmed
by sequencing the whole L1 ORF. Finally, it showed that some γ HPV
types (e.g., HPV4) are enriched in AK vs. HS, and might thus play a role
in skin carcinogenesis, thus deserving further in vivo and in vitro in-
vestigations.
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